Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma
Clinical trial NCT05487495 · WITHDRAWN
Trial details
- NCT number
- NCT05487495
- Sponsor
- Beijing Boren Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2023-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.